METASTATIC

Clinical trials for METASTATIC explained in plain language.

Never miss a new study

Get alerted when new METASTATIC trials appear

Sign up with your email to follow new studies for METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 3

Radioactive drug trial aims at rare eye cancer

Disease control Ongoing

This early-phase trial tests a radioactive drug called 225Ac-MTI-201 in 16 people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. The main goal is to find the highest safe dose and understand side effects. Participants receive a singl…

Matched conditions: METASTATIC

Phase: PHASE1 • Sponsor: Modulation Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC

METASTATIC

Get alerted when new METASTATIC trials appear

Radioactive drug trial aims at rare eye cancer